Women and Lung Cancer Research and Preventive Services Act of 2025
Click any stage to learn more about the legislative process.
Would require the Department of Health and Human Services to conduct an interagency review on lung cancer research, prevention, and awareness specifically focused on women and underserved populations, with findings and recommendations reported to Congress within two years.
What this bill would do
What it would do
The bill would direct the Secretary of Health and Human Services, in consultation with the Secretaries of Defense and Veterans Affairs, to conduct an interagency review evaluating the state of lung cancer research as it affects women and underserved populations eligible for lung cancer screening. The review would assess existing research, identify knowledge gaps, explore environmental and genomic factors, and examine imaging technology advances. It would also identify opportunities to develop a national lung cancer screening strategy and a national public education and awareness campaign on early detection.
The bill would not itself establish a screening program, fund new research, or mandate any public education campaign — it would only require the study and the submission of a report with recommendations. No appropriations are specified.
Key provisions
- 1Would require HHS, in consultation with the Departments of Defense and Veterans Affairs, to conduct an interagency review on lung cancer research, preventive services, and awareness for women and underserved populations.
- 2Would require the review to assess existing research outcomes, knowledge gaps, and collaborative research opportunities — including environmental, genomic, and imaging technology factors — related to lung cancer in women.
- 3Would require identification of opportunities to develop a national lung cancer screening strategy to expand access, particularly for women and underserved populations.
- 4Would require identification of opportunities for a national public education and awareness campaign on lung cancer in women and the importance of early detection.
- 5Would require HHS to submit a report to Congress on the review's findings within two years of enactment.
Who would be affected
The Department of Health and Human Services, Department of Defense, and Department of Veterans Affairs would be directed to collaborate on the review. Women and underserved populations who meet eligibility criteria for lung cancer screening — as defined by the U.S. Preventive Services Task Force — are the primary populations whose health needs the review would examine.
Why it matters
Women and underserved populations face documented disparities in lung cancer outcomes, and research historically has not focused on their specific risk factors and needs. If enacted, the review could shape a future national screening strategy and public awareness campaign, but the bill itself would not guarantee any direct change in services, funding, or coverage for those populations.
What would change
Agencies directed to act
Effective dates
- HHS must submit the review report to Congress
Funding and costs
Congressional Budget Office estimate
CBO estimates H.R. 2319 would cost less than $500,000 over the 2025–2030 period, with no effect on direct spending, revenues, or the deficit.
H.R. 2319 would require the Department of Health and Human Services (HHS) to submit reports to Congress on lung cancer research and screening access for women and underserved populations, as well as on related public awareness campaigns. CBO estimates the bill would cost less than $500,000 over the 2025–2030 period, based on the cost of similar reports; that spending would be subject to the availability of appropriated funds (i.e., Congress would need to provide funding). The bill would have no effect on direct (mandatory) spending, revenues, or the deficit, and CBO did not estimate costs beyond 2030. CBO identified no intergovernmental or private-sector mandates in the bill.
How implementation would work
The Secretary of Health and Human Services would lead the interagency review in consultation with the Secretaries of Defense and Veterans Affairs. The review must cover prior research outcomes, current knowledge gaps, collaborative and multidisciplinary research opportunities, national screening strategy development, and a public education campaign framework. Within two years of enactment, HHS must submit a formal report to Congress summarizing findings and recommendations. The bill sets no rulemaking requirement and creates no new program or enforcement mechanism.
Legislative status & sources
Latest action
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Official CRS summary
Show the CRS summaryHide the CRS summary
This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.
The review must
- report on the status of existing research and current knowledge gaps;
- identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
- provide recommendations for a national lung cancer screening strategy and public education campaign.
Legislative subjects
Cancer; Cardiovascular and respiratory health; Government studies and investigations; Health; Health care coverage and access; Health promotion and preventive care; Medical research; Medical tests and diagnostic methods; Women's health
Committee report
H. Rept. 119-382